What is stereotactic radiation therapy for prostate cancer? How does it compare to other treatments?
Prostate cancer is Australia's most commonly diagnosed cancer. One in six men will be diagnosed by the time they turn 85. Cancers are abnormal groups of cells that grow uncontrollably and start ...
For patients with brain metastases, treatment with an antibody-drug conjugate (ADC) at the same time as stereotactic radiotherapy significantly raises the risk of symptomatic radiation necrosis, a new ...
ZAP Surgical Systems, Inc., a global leader in non-invasive robotic brain surgery, today announced that Haaglanden Medical Center (HMC) will become the first hospital in the Netherlands to install the ...
A new study conducted by researchers at Queen Elizabeth Hospital Birmingham in Birmingham, Great Britain, evaluated outcomes and toxicity associated with stereotactic radiotherapy in patients with ...
Metastasis-directed stereotactic radiotherapy alongside biological cancer therapy appears safe, new data show.
Patritumab deruxtecan (HER3-DXd) in active brain metastases from metastatic breast and non-small cell lung cancers, and leptomeningeal disease from advanced solid tumors: The TUXEDO-3 phase II trial.
Researchers from The University of Texas MD Anderson Cancer Center will present new data at the American Society for Radiation Oncology (ASTRO) 2025 Annual Meeting demonstrating that stereotactic body ...
Stereotactic radiosurgery (SRS) and stereotactic ablative body radiotherapy (SABR) are advancing precision oncology by delivering highly accurate, high-dose radiation that achieves strong local ...
Precision-targeted radiation is proving a match for surgery in early-stage lung cancer, offering patients similar long-term survival with less invasiveness, and potentially transforming how this ...
Older adults diagnosed with kidney tumors that are not suitable for surgery may benefit from targeted, high-dose radiation, a new study from Australian and Dutch researchers suggests. A ...
Analysis of Potential Predictive Markers of Cetuximab Benefit in BMS099, a Phase III Study of Cetuximab and First-Line Taxane/Carboplatin in Advanced Non–Small-Cell Lung Cancer The article by Grills ...
Dr. Sujoy Fernandes News Editor Profile at TheHealthSite.com including Facebook and twitter profile. Checkout Latest Post by Dr. Sujoy Fernandes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results